Related Experiment Video
Updated: May 20, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Prostate Cancer: genetics in practice now and in the future
Jana McHugh1,2, Elizabeth Bancroft3,4, Zsofia Kote-Jarai3
1The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK. jana.mchugh@icr.ac.uk.
Prostate cancer (PrCa) genetics significantly influences screening, early detection, and treatment. Understanding genetic risk factors like single nucleotide polymorphisms (SNPs) aids in personalized PrCa management.
Area of Science:
- Oncology
- Genetics
- Public Health
Background:
- Prostate cancer (PrCa) is a leading global cancer with a rapidly increasing incidence, projected to double by 2040.
- Genetic factors, including monogenic variants and single nucleotide polymorphisms (SNPs), play a substantial role in PrCa heritability.
- Advances in genetic research are identifying new risk-associated SNPs, particularly with increased diversity in study populations.
Purpose of the Study:
- To review the impact of prostate cancer genetics on clinical practice.
- To explore how genetic information can inform screening and early detection strategies.
- To discuss the role of genetics in targeted treatment and management of PrCa.
Main Methods:
- Mini-review of current literature on prostate cancer genetics.
- Analysis of the relationship between genetic variants and PrCa risk.
- Examination of how genetic discoveries influence clinical decision-making.
Main Results:
- Germline variants are linked to increased PrCa risk and aggressiveness.
- Single nucleotide polymorphisms (SNPs) contribute to a calculable polygenic risk score (PRS) for PrCa.
- Genetic insights are enabling targeted therapies for specific patient groups.
Conclusions:
- Genetics is crucial for refining prostate cancer screening and early detection protocols.
- Understanding an individual's genetic profile can guide personalized treatment and management strategies.
- Continued genetic research, especially in diverse populations, is vital for advancing PrCa care.
More Related Videos
07:34Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
Cancer Prevention
Some...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Cancer Survival Analysis
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...